CHINA RESOURCES DOUBLE-CRANE PHARMA revenue breakdown overview

CHINA RESOURCES DOUBLE-CRANE PHARMA revenue for the last year amounted to 11.21 B CNY, the most of which — 8.18 B CNY — came from its highest performing source at the moment, Non-Transfusion, the year earlier bringing 7.03 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought CHINA RESOURCES DOUBLE-CRANE PHARMA 11.21 B CNY, and the year before that — 10.22 B CNY.